Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

HLA-A2 restricted CD8 T-cell line expressing MART-1 T-cell receptor

EU orphan designation number: EU/3/04/202   
Active ingredient: HLA-A2 restricted CD8 T-cell line expressing MART-1 T-cell receptor
Indication: Treatment of MART-1 positive malignant melanoma in HLA-A2 positive patients
Sponsor: Cellcure A/S
Østjysk Innovation A/S, Gustav Wieds Vej 10, 8000, Aarhus C, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2004 Orphan designation EMEA/OD/009/04 (2004)6311 of 21/06/2004
17/10/2006 Change of name and/or address of sponsor